A blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: design of the OPTIMA trial
β Scribed by D. H. Solomon; T. Gleeson; M. Iversen; J. Avorn; M. A. Brookhart; J. Lii; E. Losina; F. May; A. Patrick; W. H. Shrank; J. N. Katz
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 129 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0937-941X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Medicationβprescribing errors generated at interfacesβinβcare are the most common cause of preventable health care errors and contribute substantially to adverse patient outcomes. For this reason, standardized medication reconciliation (MR) processes need to be inserted at these interfa
## Abstract ## Objective To investigate the relationship between serum concentrations of infliximab, a monoclonal antiβtumor necrosis factor Ξ± antibody, and clinical improvement from infliximab therapy for rheumatoid arthritis (RA). ## Methods Multiple blood samples were obtained from each of 42